2.2
通常、水分バランスは視床下部渇き中枢、抗利尿ホルモン(ADH、またはバソプレシン)の合成と放出、そして腎臓のこのホルモンへの応答性という三つの相互に関連したメカニズムによって維持されます。ADHは視床下部で合成され、後下垂体から放出され、遠位腎に作用して水分の再吸収と濃縮された尿の生成を可能にします…
水分バランスは通常、視床下部の喉渇中枢、ADH分泌、腎臓のADH反応によって調節されます。
ADHはアクアポリン-2チャネルを挿入することで、集合管内での水分再吸収を促進し、尿を濃縮させます。この経路は尿崩症では機能しません。中枢性尿崩症ではADHの産生や放出が不十分であり、腎性尿崩症では腎臓がADHに反応しません。
効果的なADH作用がなければ、集水管は水に対して不透過のままで、尿中の過剰な自由水分の損失を引き起こします。これにより、通常は1日3リットル以上の多尿症が起こり、血漿の浸透圧が上昇し、激しい渇き、すなわち多点心症を引き起こします。小児では夜間遺尿症や夜尿症として現れることがあります。
継続的な水分流失は、血漿の浸透圧が正常範囲である285〜295ミリオスモル/キログラムを超えます。水分摂取量が損失と一致しない場合、脱水症状が発生します。
View the full transcript and gain access to JoVE Core videos
Q1: How does ADH normally regulate water balance in the body?
ADH, synthesized in the hypothalamus and released from the posterior pituitary, acts on the distal nephron to promote water reabsorption. ADH inserts aquaporin-2 channels into collecting duct cells, allowing water to pass through and urine to become concentrated. This mechanism maintains plasma osmolality within the normal range of 285 to 295 milliosmoles per kilogram.
Q2: What is the difference between central and nephrogenic diabetes insipidus?
In central diabetes insipidus, damage to the hypothalamus or posterior pituitary reduces or abolishes ADH secretion. In nephrogenic diabetes insipidus, ADH is produced normally, but the kidneys fail to respond due to receptor or post-receptor defects. Both forms result in collecting ducts remaining impermeable to water, causing excessive urine loss.
Q3: Why does diabetes insipidus cause excessive thirst and urination?
Without effective ADH action, collecting ducts cannot reabsorb water, leading to polyuria—typically more than three liters per day of dilute urine. This excessive water loss raises plasma osmolality above normal, triggering the hypothalamic thirst center and causing intense polydipsia. If fluid intake cannot match urinary losses, dehydration develops rapidly.
Q4: What laboratory findings are typical in diabetes insipidus?
Diabetes insipidus presents with low urine osmolality below 200 milliosmoles per kilogram, low urine specific gravity around 1.003, and elevated serum sodium above 145 milliequivalents per liter. Plasma osmolality rises above the normal range of 285 to 295 milliosmoles per kilogram. These findings reflect the kidneys' inability to concentrate urine and the resulting hypernatremia.
Q5: How do osmoregulation and baroregulation control ADH release?
Osmoregulation occurs when hypothalamic osmoreceptors detect elevated plasma osmolality and trigger ADH release to conserve water. Baroregulation activates when vascular stretch receptors sense decreased blood volume or pressure, also stimulating ADH secretion. In diabetes insipidus, these feedback systems function normally but remain ineffective due to absent ADH or renal unresponsiveness to ADH.
Q6: What are the clinical symptoms of severe diabetes insipidus?
Severe diabetes insipidus causes dehydration symptoms including dry mucous membranes, poor skin turgor, irritability, and confusion. Severe hypernatremia may trigger neurological complications such as seizures, coma, and circulatory collapse. In children, nocturnal enuresis or bedwetting may be an early presenting sign of the condition.
Q7: How does gestational diabetes insipidus differ from other forms?
Gestational diabetes insipidus occurs when excess placental vasopressinase accelerates ADH breakdown during pregnancy, reducing hormone availability. Like other forms, it results in collecting ducts remaining impermeable to water and causes polyuria and polydipsia. This type is typically reversible after delivery when placental vasopressinase production ceases.